【24h】

The two-step model for translesion synthesis: then and now.

机译:跨病变合成的两步模型:那时和现在。

获取原文
获取原文并翻译 | 示例
       

摘要

The formation of base substitution mutations following exposure of bacteria to ultraviolet light and many other mutagens occurs during translesion synthesis opposite a photoproduct or other lesion in the template strand of DNA. This process requires the UmuD(2)' UmuC complex, only formed to a significant extent in SOS-induced cells. The "two-step" model proposed that there were two steps, insertion of a wrong base (misincorporation) and use of the misincorporated base as a primer for further chain extension (bypass). The original evidence suggested that UmuD(2)' UmuC was needed only for the second step and that in its absence other polymerases such as DNA polymerase III could make misincorporations. Now we know that the UmuD(2)' UmuC complex is DNA polymerase V and that it can carry out both steps in vitro and probably does both in vivo in wild-type cells. Even so, DNA polymerase III clearly has an important accessory role in vitro and a possibly essential role in vivo, the precise nature of which is not clear. DNA polymerases II and IV are also up-regulated in SOS-induced cells and their involvement in the broader picture of translesion synthesis is only now beginning to emerge. It is suggested that we need to think of the chromosomal replication factory as a structure through which the DNA passes and within which as many as five DNA polymerases may need to act. Protein-protein interactions may result in a cassette system in which the most appropriate polymerase can be engaged with the DNA at any given time. The original two-step model was very specific, and thus an oversimplification. As a general concept, however, it reflects reality and has been demonstrated in experiments with eukaryotic DNA polymerases in vitro.
机译:细菌暴露于紫外线和许多其他诱变剂后,碱基取代突变的形成发生在与模板的DNA模板链中的光产物或其他病变相对的跨病变合成期间。此过程需要UmuD(2)'UmuC复合物,仅在SOS诱导的细胞中形成很大程度。 “两步”模型建议分两个步骤,插入错误的碱基(错误掺入)和使用错误掺入的碱基作为引物进行进一步的扩链(旁路)。原始证据表明,仅在第二步需要UmuD(2)'UmuC,并且在不存在的情况下,其他聚合酶(如DNA聚合酶III)可能会掺入错误。现在我们知道UmuD(2)'UmuC复合物是DNA聚合酶V,它可以在体外进行两个步骤,并且可能在野生型细胞中在体内完成两个步骤。即便如此,DNA聚合酶III显然仍在体外具有重要的辅助作用,而在体内可能具有重要的作用,其确切性质尚不清楚。 DNA聚合酶II和IV在SOS诱导的细胞中也被上调,它们参与更广泛的跨病变合成的作用才刚刚开始出现。建议我们将染色体复制工厂视为一种结构,DNA可以通过该结构通过,其中可能需要多达五种DNA聚合酶起作用。蛋白质-蛋白质相互作用可能会导致一个盒式系统,其中最合适的聚合酶可以在任何给定时间与DNA结合。原始的两步模型非常具体,因此过于简化。但是,作为一般概念,它反映了现实,并已在体外真核DNA聚合酶实验中得到证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号